Ragweed allergy vaccine microencapsulated extract - CuralogicAlternative Names: Microencapsulated ragweed pollen extract
Latest Information Update: 13 Mar 2009
At a glance
- Originator Curalogic
- Class Allergens; Antiallergics; Plant allergy immunotherapies
- Mechanism of Action Immunomodulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Hypersensitivity
Most Recent Events
- 05 Dec 2006 Phase-II clinical trials in Allergy in European Union (PO)
- 05 Dec 2006 Phase-II clinical trials in Allergy in USA (PO)